Avatar

Effect of Sacubitril/Valsartan on Glycemic Control in Patients with Heart Failure and Diabetes

By Jelena Seferovic
846 views
July 4, 2017
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
62:17
HeartFlow

Chest Pain in Women: CT's role in making an accurate diagnosis

Feat. L. Shaw, M. Gulati
26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne
22:14
Practical Ways to Achieve Targets in Diabetes Care

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Feat. S. Nissen
21:10
National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
29:04
15th Annual Orange County Symposium for Cardiovascular Disease Prevention

LDL-C: Earlier and Lower Is Better and Safer?

Feat. P. Rosenblit
25:54
13th Orange County Symposium for Cardiovascular Disease Prevention

SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Whic…

Feat. Y. Handelsman
30:00
Piedmont Heart Institute

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Feat. J. Burkle
24:45
National Lipid Association

Cardiovascular Disease in Patients with HIV

Feat. W. R. Short
67:29
Philips

Step Ahead - PAD & CLI State of the Art and the COVID 19 Era Imp…

Feat. C. Walker, C. Lesar, S. Madassery, T. Yates
18:42
Cardiometabolic Health Congress (CMHC)

ASCVD Risk Assessment and Prevention: Where Do We Stand Now?

Feat. S. Virani
18:02
13th Orange County Symposium for Cardiovascular Disease Prevention

The Gut Microbiome: Friend or Foe?

Feat. R. Greenfield
25:22
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

The Effect of Cancer Therapies on Diabetes

Feat. E. Gallagher
27:23
American Heart & Vascular Institute

Novel Therapies in Heart Failure: What Are the Indications and Contr…

Feat. L. Kemeyou
22:20
Cedars Sinai

What Diet Is Best for Cardiovascular Health?

Feat. K. Williams
09:29
Inova Cherry Blossom Cardiovascular Symposium 2022

The Dangerous Intersection of Diabetes and Heart (and Kidney) Disease

Feat. D. K. Mcguire